These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8438275)

  • 21. HLA-A1 in renal transplantation. Correlation of unique biochemical features with high immunogenicity.
    Dobbe CM; Thorogood J; D'Amaro J; de Lange P; Persijn GG; Giphart MJ
    Transplantation; 1995 Apr; 59(7):1053-5. PubMed ID: 7709443
    [No Abstract]   [Full Text] [Related]  

  • 22. Tissue typing and the survival of renal grafts.
    Mebel M
    Acta Med Pol; 1978; 19(1-2):67-9. PubMed ID: 367077
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing.
    Leivestad T; Sødal G; Bratlie A; Albrechtsen D; Fauchald P; Pfeffer P; Vartdal F; Thorsby E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):220-1. PubMed ID: 8438277
    [No Abstract]   [Full Text] [Related]  

  • 24. Improved renal allograft survival for AHG and DTE/AHG crossmatch-negative recipients.
    Kerman RH; Kimball PM; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Heydari A; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):400-2. PubMed ID: 1990565
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of tolerance to allogeneic major histocompatibility complex antigens on rejection across minor antigen differences.
    Smith CV; Fishbein J; Nakajima K; Rosengard BR; Guzzetta PC; Sachs DH
    Transplant Proc; 1993 Feb; 25(1 Pt 1):364-5. PubMed ID: 8438337
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
    Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal testing of seventy-six renal allograft patients for HLA antibodies: Maastricht experience.
    van den Berg-Loonen EM; Terasaki P; Kohanof S; Christiaans MH
    Clin Transpl; 2006; ():305-22. PubMed ID: 18365386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of HLA matching on kidney allograft survival.
    Suciu-Foca N; Cohen DJ; Benvenisty AI; Benstein JA; Reed EF; Ho E; Hardy MA
    Transplant Proc; 1996 Feb; 28(1):121-2. PubMed ID: 8644140
    [No Abstract]   [Full Text] [Related]  

  • 29. HLA antigens in kidney allograft rejection.
    Sujirachato K; Chiewsilp P; Jirasiritham S; Mongkolsuk T; Sumethkul V
    Transplant Proc; 1996 Jun; 28(3):1272. PubMed ID: 8658656
    [No Abstract]   [Full Text] [Related]  

  • 30. Prospective HLA typing is helpful in cadaveric renal transplantation--maybe?
    Hardy MA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):144-8. PubMed ID: 3547810
    [No Abstract]   [Full Text] [Related]  

  • 31. Reduction of the center effect by HLA matching.
    Gjertson DW; Terasaki PI; Cecka JM; Takemoto S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):215-6. PubMed ID: 8438276
    [No Abstract]   [Full Text] [Related]  

  • 32. Cadaver kidney graft outcome in relation to ischemia time and HLA match. Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1998 Dec; 30(8):4294-6. PubMed ID: 9865366
    [No Abstract]   [Full Text] [Related]  

  • 33. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
    Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG
    Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
    [No Abstract]   [Full Text] [Related]  

  • 34. Increasing the chance to accept HLA-ABDR mismatched donor in kidney transplantation.
    Sujirachato K; Chiewsilp P; Mongkolsuk T; Junpong S; Sumethkul V; Jirasiritham S; Sriphojanart S; Kanjanapanjapol S; Domrongkitchaiporn S
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S43-51. PubMed ID: 9347645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.
    Lachmann N; Terasaki PI; Schönemann C
    Clin Transpl; 2006; ():171-99. PubMed ID: 18365377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA matching in kidney transplantation: experience of a single center.
    Klouda PT; Johnson RW; Harris R; Mallick NP; Orr WM
    Transplant Proc; 1979 Jun; 11(2):1293-4. PubMed ID: 382515
    [No Abstract]   [Full Text] [Related]  

  • 37. Results with shared, six-HLA-antigen-matched cadaver renal transplants.
    Hayes JM; Steinmuller DR; Jones D; Mastroianni B; Streem S; Novick AC
    Transplant Proc; 1991 Oct; 23(5):2668-9. PubMed ID: 1926526
    [No Abstract]   [Full Text] [Related]  

  • 38. Renal function and early cadaver graft survival after continuous hypothermic perfusion with plasma protein fraction (PPF).
    Johnson RW; Cohen GL; Mallick NP; Orr WM
    Transplant Proc; 1979 Jun; 11(2):1476. PubMed ID: 382545
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of historical crossmatches and sensitization of renal allograft survival.
    Turka LA; Goguen JE; Carpenter CB; Milford EL
    Transplant Proc; 1989 Feb; 21(1 Pt 1):696-7. PubMed ID: 2650227
    [No Abstract]   [Full Text] [Related]  

  • 40. HLA matching in the new millennium.
    Takemoto SK
    Clin Transpl; 2003; ():387-403. PubMed ID: 15387124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.